Regenxbio Inc (RGNX) — Cash Flow-to-Debt Ratio
Regenxbio Inc (RGNX) has a Cash Flow-to-Debt Ratio of -0.24x as of March 2026, meaning its operating cash flow of $-76.19 Million could theoretically repay 0% of its total liabilities ($320.81 Million) in one year. Explore Regenxbio Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Regenxbio Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Regenxbio Inc across 13 annual periods. Also explore Regenxbio Inc (RGNX) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Regenxbio Inc (2013–2025)
Year-by-year debt coverage analysis for Regenxbio Inc. For market capitalisation and broader financial context, see Regenxbio Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | $-123.96 Million | $350.30 Million | ▲ +57.8% |
| 2024 | -0.84x | $-173.12 Million | $206.34 Million | ▼ -0.7% |
| 2023 | -0.83x | $-218.41 Million | $262.23 Million | ▼ -27.3% |
| 2022 | -0.65x | $-207.49 Million | $317.07 Million | ▼ -204.5% |
| 2021 | 0.63x | $218.88 Million | $349.61 Million | ▲ +482.6% |
| 2020 | -0.16x | $-54.06 Million | $330.41 Million | ▲ +92.8% |
| 2019 | -2.26x | $-107.70 Million | $47.71 Million | ▼ -175.4% |
| 2018 | 2.99x | $104.65 Million | $34.97 Million | ▲ +180.8% |
| 2017 | -3.71x | $-57.99 Million | $15.65 Million | ▲ +16.1% |
| 2016 | -4.42x | $-48.56 Million | $10.99 Million | ▲ +10.3% |
| 2015 | -4.92x | $-22.52 Million | $4.57 Million | ▼ -1786.3% |
| 2014 | -0.26x | $-2.40 Million | $9.19 Million | ▲ +59.7% |
| 2013 | -0.65x | $-3.01 Million | $4.65 Million | — |